Results 91 to 100 of about 27,539 (246)
Revista Alergia México, 2014 Background: Allergic conjunctivitis is an in ammatory disease which involves the conjunctiva, its physiopathology is a type I hypersensitivity (IgE mediated). It is related to the sensitization to indoors and out- doors aeroallergens.
Guillermina Cortés-Morales +3 more
doaj +1 more source
Allergy, EarlyView.LAR patients who respond to AIT during the first year and are treated for two more years continue improving (less symptoms and medication intake) during the following seven years. AIT prevents the onset of asthma and allergic sensitizations in responder LAR individuals during the seven years following discontinuation.
Almudena Testera‐Montes +9 more
wiley +1 more source
Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist [PDF]
Клиническая офтальмологияG.A. Azamatova1, G.R. Altynbaeva2 1Bashkir State Medical University, Ufa, Russian Federation 2City Clinical Hospital No. 5 of the city of Ufa, Ufa, Russian Federation Allergic conjunctivitis (AC) is one of the common eye diseases.
G.A. Azamatova, G.R. Altynbayeva
doaj
Over the counter ophthalmic drug misuse, are we aware? [PDF]
, 2010 Aim: To investigate the misuse of ‘over the counter’ ophthalmic medications in our city. Method: Responses of a structured questionnaire covering various aspects of over the counter drug use was obtained from pharmacy workers in and around our city ...
Achar, A, Hegde, S, Kadri, R, Kudva, AA
core +1 more source
Immunopathology of Allergic Conjunctivitis
European Medical Journal, 2018 Allergic conjunctivitis is predominantly an immunoglobulin E-mediated hypersensitivity reaction to environmental allergens. Allergic diseases affect >30% of the world’s population, of which 40% report associated ocular manifestations. Cellular and soluble mediators play a major role in the pathophysiology of allergic conjunctivitis.
DeGaulle I. Chigbu, Bhawanjot K. Minhas
openaire +2 more sources
Clinical and Molecular Effect of the Anti–IL‐18 Antibody Aletekitug in Adults With Atopic Dermatitis
Allergy, EarlyView.At Week 12, aletekitug was associated with a −68.3% percentage change from baseline in EASI score. Aletekitug improved the transcriptional profile of lesional skin towards that of non‐lesional skin at Week 4 and Week 12. Aletekitug was well‐tolerated; no serious adverse event or death occurred, and no patient withdrew due to an adverse event.
Joanne Ellis +32 more
wiley +1 more source
Community eye healthCitation: 'allergic conjunctivitis' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13037 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
Varsha M, Rathi, Somasheila I, Murthy
openaire +3 more sources
A contemporary look at allergic conjunctivitis
Allergy, Asthma & Clinical Immunology, 2020 Allergic eye disease is common, yet often overlooked in North America. In the U.S., up to 40% of the population is deemed to be affected and this number is growing.
Pascale Dupuis +3 more
doaj +1 more source
Assessing the painful, uninflamed eye in primary care [PDF]
, 2015 We acknowledge the important contributions of Professor Amada J Lee, University of Aberdeen, Division of Statistics, for assistance with analysing the data from the patient survey.
Dick, Andrew +2 more
core +1 more source
Acta Ophthalmologica, EarlyView.Abstract Purpose To investigate changes in choroidal and retinal thickness before and during myopia control treatment with orthokeratology lenses (OKL) in myopic children. Methods This was a sub‐study of CONTROL and CONTROL2 studies. The present study was a 2‐year, prospective, single‐group interventional study consisting of a 6‐month pre‐treatment ...
P. O. Hansen, F. Møller, T. M. Jakobsen
wiley +1 more source